Development of oral iron chelator L1

This publication has 9 references indexed in Scilit:

• Efficacy and possible adverse effects of the oral iron chelator 1,2- dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major [see comments]
  Blood, 1992
• Development of iron-chelating agents for clinical use [editorial; comment]
  Blood, 1992
• Reduction of tissue iron stores and normalization of serum ferritin during treatment with the oral iron chelator L1 in thalassemia intermedia
  Blood, 1992
• L1 (1,2‐dimethyl‐3‐hydroxypyrid‐4‐one) for oral iron chelation in patients with beta‐thalassaemia major
  British Journal of Haematology, 1990
• SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR
  Published by Elsevier ,1989
• Iron-Chelating Therapy
  CRC Critical Reviews in Clinical Laboratory Sciences, 1988
• Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation
  Blood, 1984
• Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human Cells
  British Journal of Haematology, 1976
• LONG‐TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA
  Annals of the New York Academy of Sciences, 1974